Clinical study of transdermal patch against traditional lepa in osteoarthritis

Exploratory clinical study of polyherbal transdermal patch against lepa in sandhigat vata (osteoarthritis) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/074084

Enrollment

Registered

2024-09-19

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M15-M19- Osteoarthritis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Classical signs and symptoms of Sandhigata vata (Osteoarthritis) – Shula, Shotha, Stambha, Sparsha-asahyata, Sphutana, Akunchana Prasarana Vedana , etc. at the joints. 2. Age: between 25 - 70 years irrespective of sex

Exclusion criteria

Exclusion criteria: 1. Patients with an auto-immune disorder like ankylosing spondylitis. 2. Patient suffering from Psoriatic arthritis, Rheumatoid arthritis, Gout and Permanent Joint Damage. 3. Pregnant women and Lactating mother.

Design outcomes

Primary

Measure	Time frame
The anticipated outcome for the exploratory clinical trial of the polyherbal transdermal patch against Lepa in Sandhigat Vata (Osteoarthritis) is that it will significantly reduce pain, improve joint function, reduce inflammation.Timepoint: 14 days	—

Secondary

Measure	Time frame
Enhance quality of life with better safety and tolerability.Timepoint: 14 days	—

Countries

India

Contacts

Public ContactOmkar Alure

Dr D Y Patil college of Ayurved and Research centre Pimpri Pune

dharkar.nilima07@gmail.com8390077907

Outcome results